Logo image of LMNX

Luminex Corp (LMNX) Stock Price, Quote, News and Overview

NASDAQ:LMNX - Nasdaq -

36.99  +0.01 (+0.03%)

After market: 37 +0.01 (+0.03%)

LMNX Quote, Performance and Key Statistics

Luminex Corp

NASDAQ:LMNX (7/13/2021, 8:00:00 PM)

After market: 37 +0.01 (+0.03%)

36.99

+0.01 (+0.03%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High41.69
52 Week Low20.61
Market Cap1.75B
Shares47.31M
Float26.61M
Yearly Dividend0.4
Dividend Yield1.08%
PE72.53
Fwd PE33.19
Earnings (Next)03-01 2022-03-01/amc
IPO03-30 2000-03-30


LMNX short term performance overview.The bars show the price performance of LMNX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30

LMNX long term performance overview.The bars show the price performance of LMNX in the last 1, 2 and 3 years. 1 year 2 years 3 years 0.5 1 1.5

The current stock price of LMNX is 36.99 null. In the past month the price increased by 0.3%. In the past year, price increased by 1.96%.

Luminex Corp / LMNX Daily stock chart

LMNX Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 24.36 203.70B
DHR DANAHER CORP 28.07 151.18B
A AGILENT TECHNOLOGIES INC 25.59 38.62B
IQV IQVIA HOLDINGS INC 17.15 33.64B
MTD METTLER-TOLEDO INTERNATIONAL 31.26 26.91B
WAT WATERS CORP 31.58 22.26B
ICLR ICON PLC 14.39 16.63B
WST WEST PHARMACEUTICAL SERVICES 31.25 15.27B
ILMN ILLUMINA INC 38.45 14.94B
RVTY REVVITY INC 23.23 13.85B
AVTR AVANTOR INC 17.3 11.78B
TEM TEMPUS AI INC N/A 10.72B

About LMNX

Company Profile

LMNX logo image Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The company is headquartered in Austin, Texas and currently employs 1,325 full-time employees. The company went IPO on 2000-03-30. The firm's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The firm has a range of instruments using its xMAP technology, which includes its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The firm primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to a range of testing laboratories.

Company Info

Luminex Corp

12212 Technology Blvd, 512-219-8020

Austin TEXAS 78727 US

CEO: Nachum Shamir

Employees: 1325.0

Company Website: http://www.luminexcorp.com/

Phone: 15122494741.0

Luminex Corp / LMNX FAQ

What is the stock price of Luminex Corp today?

The current stock price of LMNX is 36.99 null. The price increased by 0.03% in the last trading session.


What is the ticker symbol for Luminex Corp stock?

The exchange symbol of Luminex Corp is LMNX and it is listed on the Nasdaq exchange.


On which exchange is LMNX stock listed?

LMNX stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for Luminex Corp stock?

5 analysts have analysed LMNX and the average price target is 37.74 null. This implies a price increase of 2.03% is expected in the next year compared to the current price of 36.99. Check the Luminex Corp stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is Luminex Corp worth?

Luminex Corp (LMNX) has a market capitalization of 1.75B null. This makes LMNX a Small Cap stock.


How many employees does Luminex Corp have?

Luminex Corp (LMNX) currently has 1325.0 employees.


What are the support and resistance levels for Luminex Corp (LMNX) stock?

Luminex Corp (LMNX) has a support level at 36.85 and a resistance level at 37.02. Check the full technical report for a detailed analysis of LMNX support and resistance levels.


Is Luminex Corp (LMNX) expected to grow?

The Revenue of Luminex Corp (LMNX) is expected to grow by 16.71% in the next year. Check the estimates tab for more information on the LMNX EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy Luminex Corp (LMNX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does Luminex Corp (LMNX) stock pay dividends?

Luminex Corp (LMNX) has a dividend yield of 1.08%. The yearly dividend amount is currently 0.4. Check the full fundamental report for a detailed analysis of LMNX dividend history, reliability and sustainability.


When does Luminex Corp (LMNX) report earnings?

Luminex Corp (LMNX) will report earnings on 2022-03-01, after the market close.


What is the Price/Earnings (PE) ratio of Luminex Corp (LMNX)?

The PE ratio for Luminex Corp (LMNX) is 72.53. This is based on the reported non-GAAP earnings per share of 0.51 and the current share price of 36.99 null. Check the full fundamental report for a full analysis of the valuation metrics for LMNX.


LMNX Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to LMNX. When comparing the yearly performance of all stocks, LMNX is a bad performer in the overall market: 76.4% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

LMNX Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to LMNX. LMNX has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LMNX Financial Highlights

Over the last trailing twelve months LMNX reported a non-GAAP Earnings per Share(EPS) of 0.51. The EPS increased by 563.64% compared to the year before.


Industry RankSector Rank
PM (TTM) 5.39%
ROA 2.88%
ROE 4.84%
Debt/Equity 0.52
Chartmill High Growth Momentum
EPS Q2Q%533.33%
Sales Q2Q%22.41%
EPS 1Y (TTM)563.64%
Revenue 1Y (TTM)27.73%

LMNX Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 60% to LMNX. The Buy consensus is the average rating of analysts ratings from 5 analysts.

For the next year, analysts expect an EPS growth of 159.95% and a revenue growth 16.71% for LMNX


Ownership
Inst Owners0%
Ins Owners4.04%
Short Float %N/A
Short RatioN/A
Analysts
Analysts60
Price Target37.74 (2.03%)
EPS Next Y159.95%
Revenue Next Year16.71%